NYSE$AMC
AMC Entertainment Holdings Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
AMC's Q4 2020 results reflected the significant challenges posed by the COVID-19 pandemic, including widespread theatre closures and reduced attendance, resulting in a substantial revenue decline and net loss.
AMC Entertainment Holdings reported a challenging fourth quarter for 2020, heavily impacted by the COVID-19 pandemic. Revenue decreased significantly due to theatre closures and reduced attendance, leading to a substantial net loss. However, the company has taken steps to improve liquidity and is optimistic about recovery with vaccinations and theatre reopenings.
- AMC faced unprecedented challenges due to COVID-19, with significant impact on theatre operations.
- The company implemented AMC Safe & Clean protocols to ensure guest and associate safety.
- AMC focused on strengthening its liquidity profile through various financing activities.
- The company is optimistic about future recovery with increasing vaccinations and reopening of theaters.
Headline financials
Revenue & EPS history
AMC · Revenue · Quarterly
$163M
Revenue by segment
AMC · $125M total across 2 segments · Q4 2020
- Admissions$80.3M-90.8%64.2%
- Food & Beverage$44.8M-89.8%35.8%
Forward guidance
AMC did not provide specific forward guidance in this earnings report. However, the CEO expressed optimism regarding the company's ability to recover from the pandemic, citing increasing vaccination rates, the reopening of theaters in key markets, a strong slate of upcoming movie releases and a significant cash reserve.
Tailwinds
- Vaccinations are occurring in the United States at a brisk clip.
- Theatres in New York City have finally opened with theatres in Los Angeles likely opening shortly as well.
- Blockbuster movie titles are currently scheduled to be released in significant quantity in the coming few months.
- More than $1 billion of cash on hand.
- Actions have positioned AMC well to capitalize on pent-up demand for movie going as the rollout of vaccines accelerates.
Headwinds
- This past year has presented AMC with the most challenging market conditions in the 100-year history of the company.
- Many of AMC’s 467 reopened U.S. theatres suspended operations.
- Nearly all of AMC’s international theatres suspended operations.
- Limited seating capacities between 20% and 40%.
- Recorded $466.1 million of non-cash impairment charges related to long lived assets, indefinite-lived and definite-lived intangible assets and goodwill.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
-0.9%
Avg return
Earnings day
+2.6%
Avg return
5 days after
+11.8%
Avg return
30 days after
33%
13 / 39 earnings
Positive
+31.1%
Q4 2019
Best reaction
-14.8%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +10.4% | +4.2% | +35.4% | |
| Q4 2025 | -1.7% | -3.3% | -17.5% | |
| Q3 2025 | +3.2% | -2.8% | -9.2% | |
| Q1 2025 | -0.4% | +1.1% | +25.5% | |
| Q4 2024 | -0.3% | -6.7% | -11.9% | |
| Q3 2024 | -1.8% | +2.3% | +7.7% | |
| Q2 2024 | -3.9% | -5.9% | -5.9% | |
| Q1 2024 | -4.1% | +62.7% | +53.9% | |
| Q4 2023 | -9.8% | -10.2% | -22.7% | |
| Q3 2023 | -14.8% | -22.7% | -32.2% | |
| Q2 2023 | -2.3% | +2.7% | -84.1% | |
| Q1 2023 | +0.6% | -7.3% | -23.1% | |
| Q4 2022 | -8.8% | -13.5% | -34.7% | |
| Q3 2022 | -13.9% | +35.1% | +13.9% | |
| Q2 2022 | +2.5% | +23.3% | -51.2% | |
| Q1 2022 | -9.0% | -14.2% | -1.7% | |
| Q4 2021 | -2.9% | -12.1% | +30.6% | |
| Q3 2021 | +8.1% | -4.1% | -22.4% | |
| Q2 2021 | +3.4% | +2.4% | +45.0% | |
| Q1 2021 | -1.9% | +9.6% | +422.5% | |
| Q4 2020 | -6.2% | +33.7% | -10.3% | |
| Q3 2020 | -8.9% | +5.5% | +83.1% | |
| Q2 2020 | -0.2% | +9.9% | +69.2% | |
| Q1 2020 | -7.1% | -8.7% | -29.1% | |
| Q4 2019 | +31.1% | +30.3% | +85.2% | |
| Q3 2019 | -4.6% | -4.2% | -16.9% | |
| Q2 2019 | +5.8% | +2.8% | +1.5% | |
| Q1 2019 | -7.0% | -7.8% | -26.6% | |
| Q4 2018 | +1.2% | +12.6% | +7.1% | |
| Q3 2018 | -1.4% | -15.5% | -22.4% | |
| Q2 2018 | -1.5% | +6.1% | +16.9% | |
| Q1 2018 | +5.5% | +0.0% | -9.8% | |
| Q4 2017 | -1.7% | +6.3% | -6.3% | |
| Q3 2017 | +2.5% | -7.6% | +19.7% | |
| Q2 2017 | +7.6% | +2.6% | -6.3% | |
| Q1 2017 | -1.0% | -7.6% | -18.4% | |
| Q4 2016 | -0.3% | -6.5% | -1.0% | |
| Q3 2016 | +2.6% | +10.2% | +4.3% | |
| Q2 2016 | -3.3% | -1.3% | +3.4% | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q3 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro